Overview
Delirium due to benzodiazepine withdrawal is a neuropsychiatric syndrome characterized by acute changes in mental status, often presenting with confusion, agitation, and altered consciousness following abrupt cessation or significant reduction of benzodiazepine use 1.Diagnosis
Clinical presentation includes fluctuating attention, disorganized thinking, and altered levels of consciousness 1.
History of benzodiazepine use and recent cessation or dose reduction is crucial 1.
No specific laboratory tests; diagnosis primarily clinical, supported by exclusion of other causes of delirium 1.Management
Reinstitution or tapering of benzodiazepines under close monitoring is often necessary 12.
Adjunctive use of non-benzodiazepine anxiolytics or antipsychotics may be considered for severe agitation, with caution due to potential side effects 1.
Supportive care including hydration, environmental modifications, and reassurance is essential 1.Special Populations
Elderly: High prevalence of polypharmacy and inappropriate benzodiazepine prescribing increases risk; careful monitoring and dose management are critical 1.
Pediatrics: Recurrent withdrawal reactions highlight the need for gradual tapering and close observation post-discontinuation 2.Key Recommendations
Gradually taper benzodiazepines to minimize withdrawal symptoms including delirium, especially in elderly patients (Evidence: Moderate 1).
Reinstate benzodiazepines temporarily in cases of severe withdrawal-induced delirium to stabilize the patient before gradual tapering (Evidence: Weak 2).
Avoid concomitant use of interacting medications with benzodiazepines to reduce risk of adverse outcomes in vulnerable populations (Evidence: Expert opinion 1).References
1 Kummer I, Reissigová J, Lukačišinová A, Ortner Hadžiabdić M, Stuhec M, Liperoti R et al.. Polypharmacy and potentially inappropriate prescribing of benzodiazepines in older nursing home residents. Annals of medicine 2024. link
2 van Engelen BG, Gimbrere JS, Booy LH. Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam. The Annals of pharmacotherapy 1993. link